Horizon Therapeutics plc Named to the Seramount Inclusion Index

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Horizon Therapeutics plc Named to the Seramount Inclusion Index

Stifel Reiterates Buy Rating on Horizon Therapeutics (HZNP) Following Results

November 2, 2022 11:51 AM EDT

Stifel analyst Annabel Samimy reiterated a Buy rating and $138.00 price target on Horizon Therapeutics (NASDAQ: HZNP) as results showed Tepezza sales are on the mends, with peak guidance raised.

The analyst commented, "Coming off a challenging 1H22 Tepezza transitionary period, HZNP returned to solid performance, reporting revenues... More